tirzepatide methylcobalamin nad+ Compounded versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said Tirzepatide for Weight Loss —

Both share similar gastrointestinal side effects

Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk

In clinical trials conducted by Novo Nordisk, participants who were administered semi-weekly doses of Wegovy lost an average of approximately 15% of their body weight over a period ranging from 68 weeks to more than two years

For more storage-specific guidance, read TrimRxs post on how long compounded semaglutide lasts in the fridge